Perrigo (PRGO) Equity Income (2013 - 2014)
Perrigo (PRGO) reported Equity Income of $4.4 million for Q4 2014, up 4500.0% year-over-year from $95652.2 in Q4 2013, and up 241.94% quarter-over-quarter from -$3.1 million in Q3 2014.
Perrigo (PRGO) Equity Income (2013 - 2014) Analysis & Trends
Perrigo (PRGO) has 2 years of Equity Income data on file, last reported at $4.4 million in Q4 2014.
- Equity Income for Q4 2014 came in at $4.4 million, up 4500.0% year-over-year; the trailing twelve-month figure through Dec 2014 was $1.0 million (changed N/A YoY), and the FY2018 annual result was $2.7 million, up 800.0% from the prior year.
- Equity Income climbed to $4.4 million in Q4 2014 per PRGO's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Equity Income peaked at $4.4 million in Q4 2014 and troughed at -$3.8 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.68 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.91 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2014 | 4.40 Mn |
| Sep 27, 2014 | -3.10 Mn |
| Jun 28, 2014 | 3.50 Mn |
| Mar 29, 2014 | -3.80 Mn |
| Dec 28, 2013 | -100,000.00 |